Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents

Background: Cenobamate is an antiseizure medication used to treat partial-onset (focal) seizures. It is a molecule with one chiral center and a unique dual mechanism of action: enhancement of fast and slow inactivation of sodium channels with preferential inhibition of the persistent current and pos...

Full description

Bibliographic Details
Main Authors: Susan M. Melnick, Yujin Shin, Kelli J. Glenn
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023061285
_version_ 1797732946872893440
author Susan M. Melnick
Yujin Shin
Kelli J. Glenn
author_facet Susan M. Melnick
Yujin Shin
Kelli J. Glenn
author_sort Susan M. Melnick
collection DOAJ
description Background: Cenobamate is an antiseizure medication used to treat partial-onset (focal) seizures. It is a molecule with one chiral center and a unique dual mechanism of action: enhancement of fast and slow inactivation of sodium channels with preferential inhibition of the persistent current and positive allosteric modulation of GABAA receptor-mediated ion channels. Aims/Methods: Anticonvulsant effects of cenobamate (YKP3089; R-enantiomer), YKP3090 (S-enantiomer), and YKP1983 (racemate) were evaluated in chemically and electrically induced focal and generalized seizure models in rodents. The Genetic Absence Epilepsy Rat from Strasbourg (GAERS) model examined the effect of cenobamate on spike-wave seizures. Motor coordination was assessed with rotarod tests and minimal motor impairment exams. Results: Early in development, cenobamate was found to have activity in focal and generalized seizure models in animals and was selected for continued development. Cenobamate prevented seizures in a dose-dependent manner, prevented seizure spread, and increased seizure threshold without potentiating seizure initiation or the development of tolerance to its anticonvulsant effects. In contrast, YKP3090 and YKP1983 were only effective against generalized tonic-clonic seizures. Cenobamate also protected mice from 6 Hz psychomotor-induced seizures. Cenobamate showed significant dose-dependent reductions in the number and cumulative duration of spike-and-wave discharges in the GAERS model. Discussion: Cenobamate showed efficacy or efficacy signals in all animal models of epilepsy tested with a favorable risk-versus-benefit ratio, supporting its clinical use in the treatment of partial-onset (focal) seizures in adults and warranting further clinical research in generalized seizures and absence seizures.
first_indexed 2024-03-12T12:21:51Z
format Article
id doaj.art-a17f6eaf4506490690d818d4346e570a
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-12T12:21:51Z
publishDate 2023-08-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-a17f6eaf4506490690d818d4346e570a2023-08-30T05:53:06ZengElsevierHeliyon2405-84402023-08-0198e18920Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodentsSusan M. Melnick0Yujin Shin1Kelli J. Glenn2SK Life Science, Inc., Paramus, NJ, USA; Corresponding author. SK Life Science, Inc. 461 From Road, 5th Floor Paramus, NJ 07652, USA.SK Biopharmaceuticals, Co., Ltd., Seongnam, Gyeonggi, Republic of KoreaSK Life Science, Inc., Paramus, NJ, USABackground: Cenobamate is an antiseizure medication used to treat partial-onset (focal) seizures. It is a molecule with one chiral center and a unique dual mechanism of action: enhancement of fast and slow inactivation of sodium channels with preferential inhibition of the persistent current and positive allosteric modulation of GABAA receptor-mediated ion channels. Aims/Methods: Anticonvulsant effects of cenobamate (YKP3089; R-enantiomer), YKP3090 (S-enantiomer), and YKP1983 (racemate) were evaluated in chemically and electrically induced focal and generalized seizure models in rodents. The Genetic Absence Epilepsy Rat from Strasbourg (GAERS) model examined the effect of cenobamate on spike-wave seizures. Motor coordination was assessed with rotarod tests and minimal motor impairment exams. Results: Early in development, cenobamate was found to have activity in focal and generalized seizure models in animals and was selected for continued development. Cenobamate prevented seizures in a dose-dependent manner, prevented seizure spread, and increased seizure threshold without potentiating seizure initiation or the development of tolerance to its anticonvulsant effects. In contrast, YKP3090 and YKP1983 were only effective against generalized tonic-clonic seizures. Cenobamate also protected mice from 6 Hz psychomotor-induced seizures. Cenobamate showed significant dose-dependent reductions in the number and cumulative duration of spike-and-wave discharges in the GAERS model. Discussion: Cenobamate showed efficacy or efficacy signals in all animal models of epilepsy tested with a favorable risk-versus-benefit ratio, supporting its clinical use in the treatment of partial-onset (focal) seizures in adults and warranting further clinical research in generalized seizures and absence seizures.http://www.sciencedirect.com/science/article/pii/S2405844023061285EpilepsySeizuresAnimal modelsAntiseizure medicationXcopri
spellingShingle Susan M. Melnick
Yujin Shin
Kelli J. Glenn
Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
Heliyon
Epilepsy
Seizures
Animal models
Antiseizure medication
Xcopri
title Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
title_full Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
title_fullStr Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
title_full_unstemmed Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
title_short Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
title_sort anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
topic Epilepsy
Seizures
Animal models
Antiseizure medication
Xcopri
url http://www.sciencedirect.com/science/article/pii/S2405844023061285
work_keys_str_mv AT susanmmelnick anticonvulsanteffectsofcenobamateinchemicallyandelectricallyinducedseizuremodelsinrodents
AT yujinshin anticonvulsanteffectsofcenobamateinchemicallyandelectricallyinducedseizuremodelsinrodents
AT kellijglenn anticonvulsanteffectsofcenobamateinchemicallyandelectricallyinducedseizuremodelsinrodents